A recent Indianapolis Business Journal (IBJ) article takes a look back at 20 years of success for BioCrossroads, the life sciences initiative of the Central Indiana Corporate Partnership (CICP). In two decades, BioCrossroads has assisted more than 500 startup companies, raised more than $600 million of market capital and helped attract thousands of jobs. In 2022, data shows that Indiana leads the United States in pharmaceutical sales and is one of three top states for exports of all life sciences products - pharmaceuticals, medical devices, and agbiosciences, while providing an $80 billion economic impact. In 2023, BioCrossroads announced that President and CEO Patty Martin would step down to pursue other ventures. “I think it’s just a logical time right now to take a couple of months and really take a good hard, informed look at where we are overall,” said [...]

The Indianapolis Business Journal's John Russell is reporting that Indiana life sciences companies raised $115 million in venture capital funding in 2018, a three percent jump from 2017 and 133 percent higher than 2015. “The thing that jumped out at me was the variety,” said Brian Stemme, who tracks venture deals for BioCrossroads (CICP's life sciences initiative), pointing to products under development ranging from cancer drugs to tele-health software. [READ MORE] (Sources: IBJ and BioCrossroads)